Skip to main navigation
Contact Us
Investors
Media
Careers
About Us
COVID-19
See the Difference
Leadership
Board of Directors
History
Corporate Citizenship
Grants
Locations
Products
Overview
Overview
DEFINITY
®
VIALMIX
®
PINSYNC
®
TechneLite
®
Xenon-133
Calidose™ Dispenser System
AZEDRA
®
NEUROLITE
®
Thallium-201
QUADRAMET
®
Cardiolite
®
Gallium-67
Fludeoxyglucose F 18 Injection
Manufacturing & Supply Chain
Customer Service
Customer Service
FAQs
Standard Conditions of Sale
Reimbursement
Radiochemical Products
Radiochemical Products
Cobalt-57
Lead-203
Gallium-67
Xenon-133
Patent Information
Pipeline
New Product Development
Flurpiridaz F 18
LMI 1195 (CNA)
Business Development
Business Development
Art of Imaging
Overview
History of Innovation
Medical Imaging 101
Echocardiography
Nuclear Imaging
Contact Us
Investors
Media
Careers
Investor Relations
IR Contact
Mark Kinarney
Senior Director, Investor Relations
ir@lantheus.com
978-671-8842